戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 o 2.17) with association being strongest for dermatological (3.26, 2.36 to 4.57) symptoms.
2 tients (18.5%); gastrointestinal (14.8%) and dermatological (3.7%) adverse events were the most frequ
3         The most common disorder groups were dermatological (578, 17.9%), ophthalmological (496, 15.3
4  hypergammaglobulinemia, bowel inflammation, dermatological abnormalities, lymphadenopathy, and cytom
5 ssified using the Chapel Hill classification dermatological addendum.
6                                              Dermatological adverse events led to discontinuation of
7 tical ingredients (APIs) for pharmaceutical, dermatological and aesthetic applications.
8 riuretic peptide upregulated genes promoting dermatological and neuroinflammatory diseases and condit
9  but are also at risk of developing numerous dermatological and psychiatric complications.
10 imumab, or etanercept has become a staple of dermatological and rheumatological therapy.
11 ndition, with a high prevalence of fulminant dermatological and systemic manifestations and death.
12 ion of all major ATC drug categories, except dermatologicals and genito-urinary medications, was sign
13 can aid the design of optimized transdermal, dermatological, and cosmetic formulations in the future.
14 re present in a large number of transdermal, dermatological, and cosmetic products to aid dermal abso
15 ded allergic reactions (ie gastrointestinal, dermatological, and respiratory symptoms), growth, toler
16                                    We review dermatological applications of deep learning, the leadin
17 um of diseases, and our review is focused on dermatological applications.
18             The current study focuses on the dermatological aspects of the nkt mutation.
19                      We undertook a detailed dermatological assessment, syphilis serology, and PCR on
20  the void in objective methods available for dermatological assessments.
21 he New York Dermatological Society, American Dermatological Association, American Board of Dermatolog
22 inical conditions mainly rheumatological and dermatological autoimmune diseases e.g. systemic lupus e
23       Shared genetic factors impact risk for dermatological autoimmunity and anti-PD-L1 monotherapy i
24 tionship between ultraviolet (UV)-associated dermatological carcinomas (basal cell carcinoma [BCC] an
25 An estimated 3 billion people lack access to dermatological care globally.
26       New models of health care delivery for dermatological care have the potential to increase acces
27 les (10 patients) treated at 1 of 7 tertiary dermatological centers in France from September 2022 thr
28 ter study in 3 Singapore outpatient tertiary dermatological centers.
29                      The epidemiological and dermatological characteristics of IDH are described, and
30 nal and cross-sectional and was conducted in dermatological clinics across 13 European countries.
31                An ongoing concern within the dermatological community is the lack of skin disease dia
32                                            A dermatological complication of immunosuppression is vira
33 lso identified less recognized ones, such as dermatological complications.
34 ommonly referred to as dry skin, is a common dermatological condition affecting almost a third of the
35 origin of a previously undescribed recessive dermatological condition, which we named LIPHAK (LTV1-as
36 s (CD) is among the most common inflammatory dermatological conditions and includes allergic CD, phot
37                                              Dermatological conditions and poor dental health can be
38           However, applications of siRNA for dermatological conditions are limited by their poor perm
39 onal antibody treatments for immune-mediated dermatological conditions such as CSU, pemphigus, and sy
40  aesthetic reasons and for the management of dermatological conditions such as psoriasis and vitiligo
41 res have also been recognized in more common dermatological conditions such as psoriasis.
42 e vascular analysis is given for each of the dermatological conditions to show the potential diagnost
43 or dental health, low rates of immunisation, dermatological conditions, and anaemia to be substantial
44 t of inflammation, Alzheimer's disease (AD), dermatological conditions, hepatic steatosis, and oncolo
45 for the prevention and treatment of numerous dermatological conditions, patients frequently request p
46 d mice treated with topical agents and human dermatological conditions, such as contact dermatitis, a
47 easurements in clinical trials, even for non-dermatological conditions.
48 nd function, connective tissue disorders and dermatological conditions.
49 ant sensation that often accompanies chronic dermatological conditions.
50 f these, 5631 (97.9%) were genuine images of dermatological conditions.
51 o refer patients for surgery of these common dermatological conditions.
52 at least one of the top three lesions in the dermatological consensus ranking.
53                      Subsequently, collected dermatological data were subjected to post hoc analysis.
54  networks (DCNNs) and applied it to a 38,283 dermatological dataset collected from 133 patients and p
55                                              Dermatological, developmental, neurological, respiratory
56  trust and ensuring effective integration of dermatological DHTs into clinical practice.
57 e validation frameworks are being applied to dermatological DHTs.
58                                              Dermatological diagnoses increased from 851 in 2008 to 1
59                  Retrospective review of all dermatological diagnoses was performed.
60  anxiety, and suicidal ideation with various dermatological diagnoses.
61 ilar in age and sex who presented with other dermatological diagnoses.
62                                              Dermatological diagnosis remains challenging for nonspec
63  medical diagnosis recently, particularly in dermatological diagnosis, which is a very important task
64  2835 contributions that could be assigned a dermatological differential diagnosis, 2523 (89.0%) were
65  that a new measure of disability related to dermatological disease is required.
66                Psoriasis is a common chronic dermatological disease whose prevalence varies among dif
67                            For patients with dermatological disease, the Coalition of Skin Diseases (
68 ial insights into this very common childhood dermatological disease.
69 euticals have been generated against several dermatological diseases (PDT) and (antibiotic-resistant)
70 cluding allergic and irritant CD, are common dermatological diseases and are characterized by an eryt
71 e of treatment monitoring; and the effect of dermatological diseases and dermatological treatment on
72 nfection and one of the most frequently seen dermatological diseases in the intensive care unit (ICU)
73 ic modalities for the treatment of pediatric dermatological diseases in the past year.
74 iRNAs are potential therapeutics for various dermatological diseases including psoriasis, atopic derm
75                               In the case of dermatological diseases such as alopecia areata, vitilig
76 otential therapeutic applications in various dermatological diseases such as psoriasis, atopic dermat
77  sensitizers for the treatment of cancer and dermatological diseases through photodynamic therapy (PD
78 ry bowel disease, and multiple immune-driven dermatological diseases, exemplifying rapid bench-to-bed
79 aerobiology, allergen immunotherapy, asthma, dermatological diseases, food allergies, anaphylaxis, in
80 peutic success in patients with inflammatory dermatological diseases, such as acne.
81 clinical epidemiology show that inflammatory dermatological diseases, such as psoriasis, have serious
82  the skin that can foster the development of dermatological diseases.
83 nsory neurons, is associated frequently with dermatological diseases.
84 ally useful for treating certain cancers and dermatological diseases.
85 personalized precision therapeutic tools for dermatological diseases.
86 s has been linked to the outcomes of several dermatological diseases.
87 lergic conditions, including immune-mediated dermatological diseases.
88 asis on their applications for investigating dermatological diseases.
89 cally acting PDE4 inhibitor for treatment of dermatological diseases.
90 ion of sensory small fibres due to a primary dermatological disorder can cause neuropathic pain is st
91              Pruritus is a common symptom of dermatological disorders and has a major negative impact
92 mmalian skin as well as their implication in dermatological disorders and the therapy of skin disease
93                       Patient registries for dermatological disorders are important sources of data f
94 s are responsible for at least 5 overlapping dermatological disorders associated with syndromic heari
95 ed and may play a role in the sensitivity to dermatological disorders, including infectious diseases.
96 za vaccine, and did not have any significant dermatological disorders.
97 e infestations that induce psychological and dermatological distress.
98 ethasone-17-valerate (BMV), a representative dermatological drug, was determined from FFS comprising
99 or 10 s to porcine skin ex vivo, delivery of dermatological drugs and macromolecules, including those
100                                  Independent dermatological evaluation confirmed that the novel texti
101 were enrolled into our study and underwent a dermatological examination.
102 th primary mitochondrial dysfunction exhibit dermatological features including rashes and hair and pi
103 ith increased likelihood of angiomyolipomas, dermatological findings and subependymal giant cell astr
104 nd cardiometabolic diseases in patients with dermatological findings or histories.
105 recently, a novel diaper designed to deliver dermatological formulations to the skin also appears to
106                                     Genetic, dermatological, haematological, granulomatous, immunosup
107 y, cardiovascular, sexual, neurological, and dermatological health domains.
108            We trained MONET based on 105,550 dermatological images paired with natural language descr
109 tion and malignancy prediction from clinical dermatological images, which can be indistinctly acquire
110                            The Standards for Dermatological Imaging developed by the ISIC members cou
111                                Standardizing dermatological imaging is important to improve monitorin
112 he clinical application of the Standards for Dermatological Imaging set forward by the ISIC.
113 lusively associating patient complaints with dermatological implications.
114  risk than that among patients with isolated dermatological indications.
115 r widespread clinical use outside of certain dermatological indications.
116 with CO2 laser is used for a wide variety of dermatological indications.
117             CCR6 is expressed in a number of dermatological inflammatory diseases.
118 nase inhibitors at levels not detectable via dermatological inspection and histological evaluation.
119 tinal, and of course, in the first instance, dermatological involvement.
120                                  Analyses of dermatological irAEs have identified an association with
121 re ocular and periocular complications after dermatological laser treatment.
122 he ensuing systemic zinc deficiency leads to dermatological lesions and immune and reproductive dysfu
123                                           No dermatological lesions or weight loss were observed in a
124 toma braziliense is most often implicated in dermatological lesions, and Ancylostoma caninum has been
125  impact of CSU on their QoL (assessed by the Dermatological Life Quality Index) increased to 57% (n/N
126 p; most earlier studies were reported in the dermatological literature and may not be familiar to ane
127                                     Frequent dermatological manifestations (117 [93%] of 126 patients
128 gs underscore the need for assessing whether dermatological manifestations are also predictive of car
129 ve overlapping clinical characteristics, and dermatological manifestations are common.
130        Pulmonary, central nervous system and dermatological manifestations are most common.
131  mutant FGFR2b signaling may account for the dermatological manifestations of AS.
132  was collected, focusing on the most classic dermatological manifestations of IE (Osler nodes, Janewa
133 mong exposed populations do not show classic dermatological manifestations, larger and more comprehen
134 ent of reproductive and sexual function; and dermatological manifestations, mainly represented by acn
135 le in the current issue reports that classic dermatological manifestations, typically associated with
136                    Adverse events (typically dermatological) necessitated dose reduction for 61% of p
137                       There remains an unmet dermatological need for innovative topical agents that a
138               Chronic itch accompanying many dermatological, neurological, and systemic diseases is u
139 than one patient were gastrointestinal (13), dermatological (nine), metabolic (seven), fatigue (six),
140                      In addition, tacrolimus dermatological ointment rather than tacrolimus topical e
141 the patient was treated with 0.1% tacrolimus dermatological ointment, 0.1% cyclosporine eye drops, ar
142 ost frequent EIMs, preceded by articular and dermatological ones.
143 eened for anti-MDA5 antibodies at a specific dermatological or pulmonary postallograft consultation b
144 eened for anti-MDA5 antibodies at a specific dermatological or pulmonary postallograft consultation b
145 tric populations and is frequently linked to dermatological or systemic conditions.
146 personalized treatment approaches to improve dermatological outcomes for underrepresented groups.
147 s nerve endings are assumed to change due to dermatological pathologies, such as psoriasis.
148 e of, e.g., environmental factors, aging, or dermatological pathologies.
149                This article reviews relevant dermatological pathophysiology, current treatment modali
150  of 135 individual wide-field images from 68 dermatological patients not included in the DCNN trainin
151 ially to the psychological disease burden in dermatological patients, and the management of patients
152 ased risk of cardiovascular complications in dermatological patients, especially when used for short
153 ssociation between itch and mental health in dermatological patients.
154  pivotal role in improving the well-being of dermatological patients.
155                                          The dermatological perspective brings an alternative view of
156    Thus, incorporating visual learning and a dermatological perspective into urology training is esse
157 eurological, psychiatric, immunological, and dermatological phenotypes.
158    As technology becomes more commonplace in dermatological practice, it is essential to continuously
159 iagnosis and management based on the diverse dermatological presentations of sexually transmitted inf
160 up), hot flushes (44 [56%] vs 35 [25%]), and dermatological problems (10 [13%] vs 58 [42%]).
161 designs and materials have aimed at reducing dermatological problems in the diaper area.
162 utoinflammatory symptoms but unexpectedly no dermatological problems.
163 tries and Yemen, causes blindness and severe dermatological problems.
164 oach may readily be extended to a variety of dermatological processes.
165 opulmonary (shortness of breath and oedema), dermatological (pruritus and dry skin), painful (muscle
166 testinal and hepatic first-pass effects, and dermatological reactions.
167 n February 2013 and March 2015 at a tertiary dermatological referral center for anal cancer screening
168 ing non-MPXV images (n = 138,522) from eight dermatological repositories and MPXV images (n = 676) fr
169  For example, four models frequently used in dermatological research are based on the route of infect
170                              We surveyed 802 dermatological research articles from 2012 through 2013.
171 od to address specific research questions in dermatological research.
172 ents unique opportunities and challenges for dermatological research.
173 been one of the biggest challenges of recent dermatological research.
174 his cancer, who would benefit from intensive dermatological screening and immunosuppression reduction
175 acute illness and prespecified neurological, dermatological, sensory, respiratory, cardiovascular, ga
176  represent an innovative model of delivering dermatological services to patients with chronic skin di
177 atologic organizations, such as the New York Dermatological Society, American Dermatological Associat
178   Among 497 definite IE cases, 487 had known dermatological status.
179 en designing and interpreting nonhair growth dermatological studies in mice.
180 riable that influences the interpretation of dermatological studies.
181          The primary outcome measure was the dermatological sum score (DSS) assessing erythema, scali
182  and with high levels of sun exposure, close dermatological surveillance for potential skin malignanc
183 omiting, diarrhea, abdominal pain), 8.1% had dermatological symptoms (rash), 4.8% had neurological (h
184 the first reported case of the resolution of dermatological symptoms associated with a PAPA-like synd
185                                          The dermatological symptoms of both cases showed marked impr
186 ical, cardiopulmonary, gastrointestinal, and dermatological symptoms were linked to elevated risk of
187                 In seropositive individuals, dermatological symptoms were significantly more frequent
188           We sought to assess the quality of dermatological systematic reviews (SRs) and identify fac
189             It can occur in association with dermatological, systemic and neurological diseases, or b
190 s important to evaluate elderly patients for dermatological, systemic, and neurological etiologies of
191                           Moreover, systemic dermatological therapies, including retinoids, Janus kin
192 esearch will foster the development of novel dermatological therapies.
193  in the title or abstract and dealing with a dermatological topic.
194 [4%] vs none]), cytopenias (none vs 1 [4%]), dermatological toxicities (1 [4%] vs none]), hypertensio
195 ecrease tumor growth resulted in significant dermatological toxicity.
196 tion of doses of LY294002 that do not induce dermatological toxicity.
197 nd the effect of dermatological diseases and dermatological treatment on cardiovascular risk.
198 t method for minimizing bias when evaluating dermatological treatments.
199 rols were 426 children attending a pediatric/dermatological visit for nonatopic disorders matched to

 
Page Top